Try
MARAVAI LIFESCIENCES HOLDINGS, INC.
MRVIUnited States
46 filed reports · 457 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
46 reports · Dec 2020 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 78 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 24 | 76 | Dec 2020 to Jun 2026 |
| Quarterly · 10-QSEC EDGAR | 17 | 3,732 | Mar 2021 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 5 | 3,344 | Dec 2021 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 7, 2026 | 330 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Aug 6, 2026 | 2 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 8, 2026 | 245 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | May 7, 2026 | 2 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 26, 2026 | 1,091 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Feb 25, 2026 | 2 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 7, 2025 | 313 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Nov 6, 2025 | 2 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 11, 2025 | 233 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 12, 2025 | 209 | Open |
| FY2025 Q1 | 8-K | Mar 31, 2025 | May 12, 2025 | 2 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Mar 18, 2025 | 733 | Open |
Financial data
457 concepts · 7,152 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial433 concepts · 6,023 facts · Dec 2019 to Jun 2026
- Thereafter40 · Mar 2021 to Dec 2025
- Cash cash equivalents restricted cash and restricted cash equivalents34 · Dec 2019 to Jun 2026
- Adjustment for amortization33 · Dec 2019 to Jun 2026
- Allocated share based compensation expense33 · Dec 2019 to Jun 2026
- Amortization of intangible assets33 · Dec 2019 to Jun 2026
- Capital expenditures incurred but not yet paid33 · Dec 2019 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect33 · Dec 2019 to Jun 2026
- Comprehensive income net of tax33 · Dec 2019 to Jun 2026
- Comprehensive income net of tax attributable to noncontrolling interest33 · Dec 2019 to Jun 2026
- Cost of revenue (US GAAP)33 · Dec 2019 to Jun 2026
- Costs and expenses33 · Dec 2019 to Jun 2026
- Depreciation33 · Dec 2019 to Jun 2026
- Income tax expense benefit33 · Dec 2019 to Jun 2026
- Increase decrease in accounts payable33 · Dec 2019 to Jun 2026
- Increase decrease in accounts receivable33 · Dec 2019 to Jun 2026
- Increase decrease in accrued liabilities33 · Dec 2019 to Jun 2026
- Increase decrease in inventories33 · Dec 2019 to Jun 2026
- Increase decrease in other noncurrent liabilities33 · Dec 2019 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets33 · Dec 2019 to Jun 2026
- Interest paid net33 · Dec 2019 to Jun 2026
- Less: loss attributable to common non-controlling interests33 · Dec 2019 to Jun 2026
- Net cash provided by used in financing activities33 · Dec 2019 to Jun 2026
- Net cash provided by used in investing activities33 · Dec 2019 to Jun 2026
- Net cash provided by used in operating activities33 · Dec 2019 to Jun 2026
Segment13 concepts · 882 facts · Dec 2019 to Jun 2026
- Revenue493 · Dec 2019 to Jun 2026
- Operating Segments88 · Dec 2019 to Jun 2026
- Goodwill53 · Dec 2020 to Dec 2025
- Cost of revenue (US GAAP)34 · Dec 2022 to Jun 2026
- General and administrative expense (US GAAP)34 · Dec 2022 to Jun 2026
- Research and development expense34 · Dec 2022 to Jun 2026
- Segment reporting other item amount34 · Dec 2022 to Jun 2026
- Selling and marketing expense (US GAAP)34 · Dec 2022 to Jun 2026
- Goodwill acquired during period23 · Mar 2022 to Dec 2025
- Number of reporting units21 · Dec 2020 to Sep 2025
- Goodwill transfers14 · Sep 2021 to Dec 2022
- Goodwill impairment loss12 · Dec 2024 to Dec 2025
- Goodwill foreign currency translation gain loss8 · Mar 2025 to Dec 2025
Geography6 concepts · 162 facts · Dec 2019 to Jun 2026
- Revenue139 · Dec 2019 to Jun 2026
- Sale leaseback transaction current period gain recognized8 · Mar 2020 to Sep 2021
- Repayments of long term capital lease obligations6 · Mar 2020 to Sep 2021
- Operating leases rent expense net5 · Jun 2020 to Sep 2021
- Jupiter, Florida2 · Dec 2022 to Mar 2023
- San Diego, California2 · Mar 2021
Guidance4 concepts · 78 facts · Mar 2021 to Aug 2026
- Revenue Guidance50 · Mar 2021 to Aug 2026
- EPS (Diluted) Guidance24 · Mar 2021 to Nov 2023
- Capital Expenditures Guidance2 · Aug 2026
- Operating Income Guidance2 · Apr 2021
Product1 concepts · 7 facts · Dec 2019 to Dec 2025
- Cost of revenue (US GAAP)7 · Dec 2019 to Dec 2025
Segments
1,051 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments10 members · 882 facts
- Nucleic Acid Production301 · Dec 2019 to Mar 2026
- Biologics Safety Testing280 · Dec 2019 to Mar 2026
- Protein Detection94 · Dec 2019 to Dec 2023
- Cygnus77 · Dec 2023 to Jun 2026
- Tri Link77 · Dec 2023 to Jun 2026
- Biologics safety testing segment23 · Dec 2020 to Sep 2025
- Nucleic acid production segment23 · Dec 2020 to Sep 2025
- Protein detection segment3 · Dec 2020 to Mar 2021
- Cygnus segment2 · Dec 2024 to Dec 2025
- Tri link segment2 · Dec 2024 to Dec 2025
Statement geographical9 members · 162 facts
- Asia Pacific33 · Dec 2019 to Jun 2026
- EMEA33 · Dec 2019 to Jun 2026
- Latin And Central America33 · Dec 2019 to Jun 2026
- North America33 · Dec 2019 to Jun 2026
- San Diego California10 · Jun 2020 to Mar 2023
- Burlingame California8 · Mar 2020 to Sep 2021
- US7 · Dec 2023 to Jun 2026
- San Diego4 · Mar 2020 to Mar 2021
- Leland North Carolina1 · Dec 2022
Product or service1 member · 7 facts
- Shipping And Handling7 · Dec 2019 to Dec 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 6, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.